Thank you, Mr. Chairman.
Ms.Wong-Rieger, there are some points from your recent exchange with Ms. Bennett that I am trying to understand. Given the fact that there are so few cases in Canada in which clinical studies have shown that a drug is effective for rare disorders, do you think that Canadian cases should be linked with other international cases in order to conduct more conclusive studies?